Page last updated: 2024-10-21

edelfosine and Cancer of Liver

edelfosine has been researched along with Cancer of Liver in 4 studies

edelfosine: RN given refers to parent cpd
edelfosine : A racemate comprising equimolar amounts of (R)- and (S)-edelfosine.
1-octadecyl-2-methylglycero-3-phosphocholine : A glycerophosphocholine that is glycero-3-phosphocholine substituted at positions 1 and 2 by octadecyl and methyl groups respectively.

Research Excerpts

ExcerptRelevanceReference
"Patients with liver cirrhosis of different aetiologies are at a risk to develop HCC."2.66Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma. ( Aslanidis, C; Buechler, C, 2020)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Buechler, C1
Aslanidis, C1
Carrasco, MP1
Jiménez-López, JM1
Ríos-Marco, P1
Segovia, JL1
Marco, C1
Na, HK1
Chang, CC1
Trosko, JE1
Guo, HB1
Shen, ZH1
Huang, CX1
Ma, J1
Huang, Y1
Chen, HL1

Reviews

1 review available for edelfosine and Cancer of Liver

ArticleYear
Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma.
    Biochimica et biophysica acta. Molecular and cell biology of lipids, 2020, Volume: 1865, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Prolif

2020

Other Studies

3 other studies available for edelfosine and Cancer of Liver

ArticleYear
Disruption of cellular cholesterol transport and homeostasis as a novel mechanism of action of membrane-targeted alkylphospholipid analogues.
    British journal of pharmacology, 2010, Volume: 160, Issue:2

    Topics: Antineoplastic Agents; Biological Transport; Blotting, Western; Carcinoma, Hepatocellular; Cell Line

2010
Growth suppression of a tumorigenic rat liver cell line by the anticancer agent, ET-18-O-CH(3), is mediated by inhibition of cytokinesis.
    Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:3

    Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Differentiation; Cell Division; Dose-Response Relat

2003
Modulation of the basal activity of phosphatidylinositol-3-kinase/protein kinase B signaling pathway in human hepatocarcinoma cells.
    Glycoconjugate journal, 2000, Volume: 17, Issue:5

    Topics: Antibodies, Monoclonal; Carcinoma, Hepatocellular; Chromones; DNA, Antisense; Enzyme Activation; Enz

2000